nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case report of congenital erythropoietic anemia II in China with a novel mutation
|
Zhang, Hong |
|
2019 |
98 |
4 |
p. 1041-1043 |
artikel |
2 |
Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 years
|
Zhang, Ying |
|
2019 |
98 |
4 |
p. 997-1007 |
artikel |
3 |
Anti-glomerular basement membrane disease due to monoclonal IgG Lambda antibodies: a very rare case of monoclonal gammopathy of renal significance
|
Peña, C. |
|
2018 |
98 |
4 |
p. 1045-1046 |
artikel |
4 |
An under-recognized cause of copper deficiency mimicking myelodysplastic syndrome
|
Stafford, Margaret A. |
|
2018 |
98 |
4 |
p. 1021-1023 |
artikel |
5 |
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
|
Ma, Tiantian |
|
2019 |
98 |
4 |
p. 813-822 |
artikel |
6 |
Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era
|
Chen, Lei |
|
2019 |
98 |
4 |
p. 963-970 |
artikel |
7 |
Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes
|
Brancaleoni, Valentina |
|
2018 |
98 |
4 |
p. 833-840 |
artikel |
8 |
Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
|
Bianchi, Monica |
|
2018 |
98 |
4 |
p. 971-977 |
artikel |
9 |
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies
|
Zhang, Yu-Lin |
|
2019 |
98 |
4 |
p. 1009-1020 |
artikel |
10 |
Deciphering the prognostic significance of autoimmune disorders in myelodysplastic syndromes
|
Fozza, Claudio |
|
2018 |
98 |
4 |
p. 1025-1026 |
artikel |
11 |
Early detection value of 18F-FDG-PET/CT for drug-induced lung injury in lymphoma
|
Zhao, Meixin |
|
2018 |
98 |
4 |
p. 909-914 |
artikel |
12 |
High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma
|
Cai, Yu |
|
2019 |
98 |
4 |
p. 823-831 |
artikel |
13 |
High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease
|
Makishima, Kenichi |
|
2018 |
98 |
4 |
p. 1031-1032 |
artikel |
14 |
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib
|
Breccia, Massimo |
|
2018 |
98 |
4 |
p. 889-896 |
artikel |
15 |
Incidence, risk factors, and clinical significance of Epstein–Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation
|
Wang, Hong |
|
2019 |
98 |
4 |
p. 987-996 |
artikel |
16 |
Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial
|
Langer, Arielle L. |
|
2019 |
98 |
4 |
p. 841-849 |
artikel |
17 |
Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage
|
Canichella, Martina |
|
2018 |
98 |
4 |
p. 1047-1048 |
artikel |
18 |
Low-dose splenic irradiation is an alternative therapy for symptomatic splenomegaly in patients with myelofibrosis
|
Huang, Ming-Shan |
|
2018 |
98 |
4 |
p. 1037-1040 |
artikel |
19 |
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
|
Gill, Harinder |
|
2018 |
98 |
4 |
p. 869-879 |
artikel |
20 |
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia.
|
Ysebaert, Loic |
|
2019 |
98 |
4 |
p. 931-939 |
artikel |
21 |
Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study
|
Xhaard, Aliénor |
|
2018 |
98 |
4 |
p. 1033-1035 |
artikel |
22 |
(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study
|
Collignon, A. |
|
2018 |
98 |
4 |
p. 915-922 |
artikel |
23 |
Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia
|
Tan, Chuen Wen |
|
2018 |
98 |
4 |
p. 861-868 |
artikel |
24 |
Secondary diffuse large B cell lymphoma of the central nervous system: retrospective review of case series
|
Tashkandi, Hammad |
|
2018 |
98 |
4 |
p. 1049-1050 |
artikel |
25 |
Simplified novel prognostic score for real-life older adults with multiple myeloma—registry-based analysis
|
Radocha, J. |
|
2018 |
98 |
4 |
p. 951-962 |
artikel |
26 |
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
|
Hüttmann, Andreas |
|
2019 |
98 |
4 |
p. 897-907 |
artikel |
27 |
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries
|
Hungria, Vania T. M. |
|
2019 |
98 |
4 |
p. 941-949 |
artikel |
28 |
The burden of psychiatric illnesses in adult patients with beta-thalassemia: a 5-year nationwide inpatient evaluation in the United States
|
Patel, Krupa |
|
2018 |
98 |
4 |
p. 851-860 |
artikel |
29 |
Therapeutic strategies for durable response in plasma cell granulomas in the central nervous system
|
Patel, Ameet |
|
2018 |
98 |
4 |
p. 1027-1029 |
artikel |
30 |
The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphoma
|
Wu, Ting |
|
2019 |
98 |
4 |
p. 923-930 |
artikel |
31 |
Treatment patterns and comparative analysis of non-intensive regimens in elderly acute myeloid leukemia patients—a real-world experience from India
|
Kanakasetty, Govind B. |
|
2019 |
98 |
4 |
p. 881-888 |
artikel |
32 |
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation
|
Tamma, Roberto |
|
2018 |
98 |
4 |
p. 979-986 |
artikel |